The research prospect on ferroptosis induced by auraptene in hepatocellular carcinoma cells

References

[1] Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021; 218(1):e20201606. doi: 10.1084/jem.20201606

[2] Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021; 7(1):6. doi: 10.1038/s41572-020-00240-3

[3] Bian XL, Chen HZ, Yang PB, et al. Nur 77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation. Nat Commun. 2017;8:14420. doi: 10.1038/ncomms14420

[4] Hou PP, Luo LJ, Chen HZ, et al. Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment. Mol Cell. 2020; 78(6):1192-1206.e10. doi: 10.1016/j.molcel.2020.05.004

[5] Jiang X, Stockwell BR, Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021; 22(4):266-282. doi: 10.1038/s41580-020-00324-8

[6] Yang H, Dai B, Chen L, et al. Iberverin downregulates GPX4 and SLC7A11 to induce ferroptotic cell death in hepatocellular carcinoma cells. Biomolecules. 2024; 14(11):1407. doi: 10.3390/biom14111407

[7] Deguang L, Yan F, Fereshteh Z, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023; 186:2748-2764.e22. doi: 10.1016/j.cell.2023.05.003

[8] Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1):317-331. doi: 10.1016/j.cell.2013.12.010

[9] Yu W, Li Y, Gao C, et al. MDH2 Promotes hepatocellular carcinoma growth through ferroptosis evasion via stabilizing GPX4. Int J Mol Sci. 2024; 25(21):11604. doi: 10.3390/ijms252111604

[10] Ogawa K, Kawasaki A, Yoshida T, et al. Evaluation of auraptene content in Citrus fruits and their products. J Agric Food Chem. 2000; 48(5):1763-1769. doi: 10.1021/jf9905525

[11] Sunagawa Y, Kawaguchi S, Miyazaki Y, et al. Auraptene, a Citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARAR α in rats Phytomedicine. 2022;107:154457. doi: 10.1016/j.phymed.2022.154457

[12] Ebrahimi S, Soukhtanloo M, Mostafavi-Pour Z. Anti-tumor effects of Auraptene through induction of apoptosis and oxidative stress in a mouse model of colorectal cancer. Tissue Cell. 2023;81:102004. doi: 10.1016/j.tice.2022.102004

[13] Ghorbani M, Soukhtanloo M, Farrokhi AS, et al. Auraptene-induced cytotoxic effects in acute myeloid leukemia cell lines. Med Oncol. 2023; 40(8):231. doi: 10.1007/s12032-023-02088-5

[14] Li D, Li Y, Chen L, et al. Natural product auraptene targets SLC7A11 for degradation and induces hepatocellular carcinoma ferroptosis. Antioxidants. 2024; 13(8):1015. doi: 10.3390/antiox13081015

[15] Tayarani-Najaran Z, Tayarani-Najaran N, Eghbali S. A review of auraptene as an anticancer agent. Front Pharmacol. 2021;12:698352. doi: 10.3389/fphar.2021.698352

[16] Maleki EH, Bahrami AR, Sadeghian H, Matin MM. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells. Toxicol In Vitro. 2020;63:104745. doi: 10.1016/j.tiv.2019.104745

[17] Vakili T, Iranshahi M, Arab H, Riahi B, Roshan NM, Karimi G. Safety evaluation of auraptene in rats in acute and subacute toxicity studies. Regul Toxicol Pharmacol. 2017; 91:159-164. doi: 10.1016/j.yrtph.2017.10.025

[18] Ye X, Ouyang H, Zhong L, et al. Rapid and sensitive LC-MS/MS method for the determination of auraptene in rat plasma and its application in a pharmacokinetic and bioavailability study in rats. G enet Mol Res. 2016; 15:4238. doi: 10.4238/gmr.15028786